Beryl Drugs Ltd
Beryl Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Beryl Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Beryl Drugs Ltd Share Price Chart
BERYLDRUGS at 06 Feb 2026 04:12 PM Pharmaceuticals
21.07 +0.03(+0.14%)
Lowest Today 21.07
Highest Today 22.25
Today's Open 22.00
Prev. Close 21.04
52 Week High 35.99
52 Week Low 17.35
Beryl Drugs Ltd Fundamentals
Traded Volume: 680
Market Cap(Cr): 11
Avg Traded Price 21.84
1 Year return -37.61%
Upper Circuit 22.2
Lower Circuit 21.1
P/E TTM 0.00
P/B Ratio 1.128
Traded Value(Cr) 0.14
EPS TTM NaN
Book value/Share 18.660
Dividend Yield 1Y 0.00%
Beryl Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Beryl Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Beryl Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -37.61%
YTD 0.00%
Beryl Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Beryl Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Beryl Drugs Ltd Technical Details
Beryl Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 20
Support 2 20
Support 3 18
Pivot Point : 22
Resistance 1 22
Resistance 2 24
Resistance 3 24
Beryl Drugs Ltd Corporate Actions
Beryl Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Beryl Drugs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by BERYLDRUGS
Bonus
No Bonus has been declared by BERYLDRUGS
Splits
No Split has been declared by BERYLDRUGS
Others
Rights No Rights has been declared by BERYLDRUGS
Beryl Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Beryl Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Beryl Drugs Ltd's relative performance and valuation against major competitors.
Beryl Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Beryl Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 2.64 Mar 2024 1.01 Mar 2023 2.48 Mar 2022 -0.29 Mar 2021 0.38
PARTICULARS Investing Activities Mar 2025 -0.40 Mar 2024 -1.26 Mar 2023 -1.30 Mar 2022 0.54 Mar 2021 0.26
PARTICULARS Financing Activities Mar 2025 -1.55 Mar 2024 0.09 Mar 2023 -1.17 Mar 2022 -0.43 Mar 2021 -0.58
PARTICULARS Net Cash Flow Mar 2025 0.69 Mar 2024 -0.16 Mar 2023 0.01 Mar 2022 -0.18 Mar 2021 0.06
Beryl Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Beryl Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Beryl Drugs Ltd
Beryl Drugs Limited was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V. fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplocillin INJ, P-Mol, Biprox, B-Flox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Managing Director
Sanjay Sethi
Registered office 133 Kanchan Bag, , Indore, Madhya Pradesh, 452001
FAX :91-731-25076375/3046366
Background
Incorporation Year 1993
Face Value ₹10.00
Market Lot 1
FAQs on Beryl Drugs Ltd
How to buy Beryl Drugs Ltd shares on NSE?
To buy Beryl Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Beryl Drugs Ltd share price today?
The Beryl Drugs Ltd share price on NSE is ₹21.07 today.
What is the market cap of Beryl Drugs Ltd on NSE?
The company has a market capitalization of ₹10.69.
What is the PE & PB ratio of Beryl Drugs Ltd?
PE is N/A and PB is 1.128.
What is the 52 Week High and Low of Beryl Drugs Ltd shares?
Beryl Drugs Ltd stock price high: ₹35.99 Beryl Drugs Ltd stock price low: ₹17.35.